| Literature DB >> 33987198 |
Amir Bagheri1, Rezvan Hashemi2, Ramin Heshmat3, Ahmadreza Dorosty Motlagh1, Ahmad Esmaillzadeh1,4,5.
Abstract
Background: Despite the associations between individual nutrients and sarcopenia, we are aware of no information about the link between patterns of nutrient intake and odds of sarcopenia and its components. The present study aimed to examine the association between nutrient-based dietary patterns and sarcopenia and its components among the Iranian adult population.Entities:
Keywords: gait speed; muscle mass; muscle strength; nutrient patterns; sarcopenia
Year: 2021 PMID: 33987198 PMCID: PMC8110707 DOI: 10.3389/fnut.2021.645072
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Component of the nutrient-based dietary patterns.
| Pantothenic | 0.245 | 0.271 | |
| Cobalamin (B12) | |||
| Calcium | 0.294 | ||
| Protein | 0.405 | 0.269 | |
| Phosphor | 0.420 | 0.278 | |
| Riboflavin (B2) | 0.245 | 0.470 | |
| Zinc | 0.520 | 0.229 | |
| Cholesterol | 0.282 | ||
| Saturated fat | 0.549 | ||
| folate | 0.494 | 0.425 | |
| Niacin | 0.509 | 0.403 | |
| Selenium | 0.281 | 0.221 | |
| Vitamin D | |||
| Vitamin K | 0.300 | 0.266 | |
| Vitamin A | 0.212 | 0.302 | |
| Poly-fat | |||
| Mono-fat | 0.316 | ||
| Copper | 0.249 | 0.388 | |
| Vitamin E | |||
| Omega-3 | 0.250 | ||
| Magnesium | 0.554 | 0.429 | |
| Iron | 0.493 | 0.448 | |
| Pyridoxine | 0.222 | 0.525 | |
| Sodium | |||
| caffein | |||
| Fructose | |||
| Glucose | |||
| Dietary fiber | 0.245 | 0.390 | |
| Biotin | 0.349 | ||
| Potassium | 0.517 | 0.341 | |
| Thiamin | 0.464 | 0.431 | |
| Vitamin C | 0.275 | 0.283 | |
| Chromium | 0.248 | ||
| Percent of variance explained | |||
Factor loadings <0.2 were omitted due to simplicity. The bold values show the major nutrient's factor loading in each pattern.
General characteristics of the study participants across categories of nutrient-based dietary pattern scores.
| Age (y) | 66.8 ± 7.7 | 67.3 ± 8.1 | 66.2 ± 7.3 | 0.60 | 67.8 ± 7.9 | 66.8 ± 7.7 | 65.7 ± 7.3 | 0.14 | 66.7 ± 7.7 | 66.4 ± 8.1 | 67.1 ± 7.3 | 0.80 |
| BMI (kg/m2) | 27.59 ± 3.7 | 27.14 ± 4.5 | 27.4 ± 4.4 | 0.75 | 27.32 ± 3.9 | 27.45 ± 4.3 | 27.37 ± 4.3 | 0.97 | 27.62 ± 4.5 | 27.12 ± 3.6 | 27.4 ± 4.4 | 0.01 |
| PA (MET-h/w) | 1129.7 ± 989.1 | 1104.3 ± 1298.3 | 1649.5 ± 1821.2 | 0.01 | 1063.4 ± 1201.1 | 1190.3 ± 1478.6 | 1629.8 ± 1537.7 | 0.01 | 1082.6 ± 940.5 | 1160.5 ± 1565.2 | 1640.4 ± 1628.9 | 0.70 |
| Female (%) | 35.9 | 34 | 30.1 | 0.43 | 37.3 | 35.3 | 27.4 | 0.08 | 34 | 34.6 | 31.4 | 0.75 |
| Alcohol use (%) | 37.5 | 22.5 | 40 | 0.28 | 15 | 37.5 | 47.5 | 0.02 | 35 | 37.5 | 27.5 | 0.68 |
| Smoking (%) | 47.4 | 21.1 | 31.5 | 0.10 | 13.2 | 39.4 | 47.4 | 0.01 | 50 | 26.3 | 23.7 | 0.06 |
| Medical history | ||||||||||||
| Yes (%) | 36.5 | 30.8 | 32.7 | 0.85 | 40.4 | 28.8 | 30.8 | 0.48 | 28.8 | 34.6 | 36.6 | 0.73 |
| No (%) | 32.7 | 33.8 | 33.5 | 31.9 | 34.3 | 33.8 | 34.3 | 33.1 | 32.6 | |||
| Drug history use | ||||||||||||
| Sexual hormone (%) | 33.3 | 33.3 | 33.4 | 1.00 | 44.4 | 22.2 | 33.4 | 0.70 | 22.2 | 44.4 | 33.4 | 0.70 |
| Statin (%) | 33.6 | 38.2 | 28.2 | 0.27 | 30.9 | 37.3 | 31.8 | 0.53 | 25.5 | 36.4 | 38.1 | 0.80 |
| Corticosteroid (%) | 37.5 | 25 | 37.5 | 0.88 | 37.5 | 25 | 37.5 | 0.88 | 25 | 50 | 25 | 0.60 |
All values are mean ± SD, unless indicated;
ANOVA for continuous variables and chi-squared test for categorical variables.
Dietary intakes of study participants across categories of nutrient-based dietary pattern scores.
| Fruits | 605.8 ± 27.5 | 681.7 ± 26.4 | 665.5 ± 27.9 | 0.12 | 609.2 ± 27.2 | 668.9 ± 26.6 | 675.5 ± 28 | 0.17 | 487.4 ±22.7 | 598.2 ± 22 | 866.2 ± 23 | <0.01 |
| Vegetables | 470.4 ± 25.1 | 527.1 ± 24.2 | 565.1 ± 25.6 | 0.04 | 462.9 ± 24.8 | 529.8 ± 24.2 | 569.7 ± 25.6 | 0.14 | 393.1 ±22 | 477.7 ±21.5 | 691.6 ±22.4 | 0.01 |
| legumes and nuts | 46.9 ± 3.5 | 52.8 ± 3.3 | 56.9 ± 3.5 | 0.15 | 46.7 ± 3.4 | 48.4 ± 3.3 | 61.6 ± 3.5 | 0.01 | 50.4 ± 3.4 | 56.3 ± 3.3 | 49.9 ± 3.5 | 0.34 |
| Dairy products | 360.1 ± 25.6 | 498.7 ± 24.7 | 819.1 ± 26.2 | <0.01 | 681.9 ± 30.1 | 524.1 ± 29.3 | 471.8 ± 30.9 | <0.01 | 547.9 ±31.2 | 565.9 ±30.4 | 563.9 ±31.7 | 0.90 |
| Whole grains | 46.1 ± 7.1 | 55.7 ± 6.8 | 84.1 ± 7.2 | 0.01 | 70.7 ± 7.1 | 57.4 ± 6.9 | 57.7 ± 7.3 | 0.32 | 51.6 ± 7.1 | 64.6 ± 6.9 | 69.7 ± 7.2 | 0.20 |
| Refined grains | 246.9 ± 18.2 | 268.1 ± 17.5 | 246.6 ± 18.5 | 0.61 | 245.4 ± 18 | 274.5 ± 17.5 | 241.6 ± 18.5 | 0.35 | 245.7 ± 18 | 265.1 ± 17.5 | 250.8 ± 18.3 | 0.72 |
| Sweets and deserts | 6.7 ± 0.9 | 7.9 ± 0.9 | 4.6 ± 0.9 | 0.04 | 5.1 ± 0.96 | 6.1 ± 0.94 | 8.1 ± 0.99 | 0.13 | 7.9 ± 0.9 | 7.4 ± 0.9 | 4.2 ± 0.9 | 0.03 |
| Red meats | 29.9 ± 3 | 34.1 ± 2.9 | 42.2 ± 3.1 | 0.02 | 27.7 ± 2.9 | 36.7 ± 2.8 | 41.8 ± 3.1 | 0.05 | 42.9 ± 2.9 | 35.6 ± 2.8 | 27.7 ± 3 | 0.01 |
| White meats | 31.6 ± 3.1 | 39.2 ± 2.9 | 45.5 ± 3.1 | 0.01 | 37.9 ± 3.1 | 36.6 ± 3 | 41.9 ± 3.2 | 0.47 | 43.2 ± 3.1 | 37.7 ± 3 | 35.4 ± 3.1 | 0.21 |
| Vegetable oils | 11.5 ± 0.9 | 10.9 ± 0.8 | 9.5 ± 0.9 | 0.29 | 8.9 ± 0.9 | 10.5 ± 0.8 | 12.4 ± 0.9 | 0.03 | 10.9 ± 0.8 | 11 ± 0.8 | 9.9 ± 0.9 | 0.68 |
| Energy | 1857.2 ± 84 | 2165.1 ±84 | 2766.3 ± 84 | <0.01 | 1929.6 ± 85.5 | 2103.8 ±85 | 2755.2 ± 85.8 | 0.01 | 1901.8 ± 85.3 | 2165.9 ± 85.4 | 2721.1 ± 85.4 | <0.01 |
| Carbohydrate (g/d) | 380.6 ± 5.5 | 367.4 ± 5.3 | 350.1 ± 5.6 | 0.01 | 386.3 ± 5.2 | 374.8 ±5.1 | 336.8 ± 5.4 | <0.01 | 349.2 ± 5.4 | 362.5 ±5.3 | 386.3 ±5.5 | <0.01 |
| Protein (g/d) | 72.3 ± 1.4 | 83.5 ± 1.4 | 102.3 ± 1.5 | <0.01 | 87.7 ± 1.8 | 84.6 ± 1.8 | 85.7 ± 1.9 | 0.47 | 86.2 ± 1.8 | 87.1 ± 1.8 | 84.8 ± 1.8 | 0.70 |
| Fats (g/d) | 60.8 ± 1.9 | 60.1 ± 1.8 | 56.9 ± 1.9 | 0.37 | 50.4 ± 1.7 | 56.1 ± 1.7 | 71.1 ± 1.8 | <0.01 | 65.6 ± 1.8 | 59.7 ± 1.8 | 52.5 ± 1.9 | <0.01 |
| Dietary Fiber (g/d) | 31.1 ± 0.8 | 30.5 ± 0.7 | 28.3 ± 0.9 | 0.08 | 29.7 ± 0.8 | 30.7 ± 0.8 | 29.5 ± 0.9 | 0.61 | 25.1 ± 0.7 | 28.8 ± 0.7 | 36.1 ± 0.7 | <0.01 |
| Calcium (mg/d) | 1039.1 ± 35.9 | 1250.9 ± 34.6 | 1726.9 ± 36.6 | <0.01 | 1521.5 ± 42.8 | 1299.7 ± 41.7 | 1195.7 ± 44.1 | <0.01 | 1273.1 ± 44.4 | 1350.5 ± 43.3 | 1393.3 ± 45.2 | 0.17 |
| Vitamin E (mg/d) | 10.5 ± 0.5 | 9.8 ± 0.4 | 7.8 ± 0.5 | 0.01 | 6.9 ± 0.4 | 8.3 ± 0.4 | 12.9 ± 0.4 | <0.01 | 10.6 ± 0.5 | 9.2 ± 0.4 | 8.5 ± 0.5 | 0.02 |
| Vitamin B6 (mg/d) | 2.8 ± 0.1 | 2.6 ± 0.1 | 2.4 ± 0.1 | 0.10 | 2.7 ± 0.13 | 2.6 ± 0.12 | 2.5 ± 0.13 | 0.58 | 2.3 ± 0.12 | 2.5 ± 0.12 | 2.9 ± 0.13 | 0.01 |
| Folate (mcg/d) | 496.3 ± 11.3 | 541.3 ± 10.9 | 593.1 ± 11.6 | <0.01 | 512.3 ± 11.6 | 541.5 ± 11.3 | 576.8 ± 12 | 0.01 | 479.8 ±10.6 | 538.3 ±10.3 | 612.5 ±10.8 | <0.01 |
All values are mean ± SE; energy intake is adjusted for age and sex; all other values are adjusted for age, sex, and energy intake.
ANCOVA for all variables.
Prevalence of sarcopenia and its components across tertile categories of nutrient-based dietary pattern patterns.
| low muscle mass (%) | 34.2 | 33.3 | 32.5 | 0.96 | 35 | 35 | 30 | 0.60 | 35 | 32.5 | 32.5 | 0.88 |
| low handgrip strength (%) | 31.3 | 34.4 | 34.3 | 0.87 | 42.7 | 30.2 | 27.1 | 0.05 | 35.4 | 26 | 38.6 | 0.16 |
| low gait speed (m/s) (%) | 34.4 | 36.9 | 28.7 | 0.34 | 35.2 | 38.5 | 26.3 | 0.08 | 39.3 | 33.6 | 27.1 | 0.09 |
| Sarcopenia (%) | 31.5 | 42.6 | 25.9 | 0.24 | 46.3 | 35.2 | 18.5 | 0.02 | 38.9 | 31.5 | 29.6 | 0.62 |
| Means of components | ||||||||||||
| Muscle mass [ASM/h2] (kg) | ||||||||||||
| Crude | 6.5 ± 0.1 | 6.5 ± 0.1 | 6.7 ± 0.1 | 0.43 | 6.4 ± 0.1 | 6.6 ± 0.1 | 6.7 ± 0.1 | 0.07 | 6.5 ± 0.1 | 6.5 ± 0.1 | 6.7 ± 0.1 | 0.26 |
| Model 1 | 6.5 ± 0.08 | 6.6 ±0.08 | 6.6 ± 0.08 | 0.81 | 6.5 ± 0.08 | 6.6 ± 0.08 | 6.6 ± 0.08 | 0.49 | 6.6 ± 0.08 | 6.5 ± 0.08 | 6.7 ± 0.08 | 0.25 |
| Hand grip strength (psi) | ||||||||||||
| Crude | 10.8 ± 0.3 | 10.7 ±0.3 | 11.5 ± 0.3 | 0.29 | 10.2 ± 0.3 | 10.9 ± 0.3 | 11.9 ± 0.3 | <0.01 | 11.1 ± 0.3 | 11.2 ± 0.3 | 10.9 ± 0.3 | 0.84 |
| Model 1 | 11.1 ± 0.2 | 10.9 ±0.2 | 11.2 ± 0.2 | 0.67 | 10.6 ± 0.2 | 11.1 ± 0.2 | 11.4 ± 0.2 | 0.07 | 11.1 ±0.2 | 11.2 ±0.2 | 10.8 ± 0.2 | 0.42 |
| Gait speed (m/s) | ||||||||||||
| Crude | 0.8 ± 0.02 | 0.8 ±0.02 | 0.8 ± 0.02 | 0.08 | 0.83 ± 0.02 | 0.83 ±0.02 | 0.86 ±0.02 | 0.45 | 0.82 ± 0.02 | 0.85 ± 0.2 | 0.85 ± 0.01 | 0.43 |
| Model 1 | 0.83 ± 0.02 | 0.82 ± 0.02 | 0.87 ± 0.02 | 0.20 | 0.85 ± 0.02 | 0.83 ± 0.02 | 0.84 ± 0.02 | 0.85 | 0.82 ± 0.02 | 0.85 ± 0.02 | 0.85 ± 0.02 | 0.46 |
Obtained from ACNOVA for quantitative variables and chi-square for qualitative variables (P < 0.05 significant).
Muscle mass lower than 5.45 (kg/m.
Muscle strength lower than 20 kg for women and 30 kg for men was considered low (.
Gait speeds lower than 0.8 m/s were considered low (.
Model 1: Adjusted for energy, age and sex.
Multivariable-adjusted odds ratios (95% CIs) for sarcopenia and its components across tertile categories of nutrient-based dietary patterns.
| Sarcopenia | ||||||||||||
| 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||
| Crude | 1 | 1.46 | 0.79 | 0.58 | 1 | 0.70 | 0.33 | <0.01 | 1 | 0.77 | 0.72 | 0.36 |
| Model 1 | 1 | 1.36 | 0.69 | 0.44 | 1 | 0.67 | 0.25 | <0.01 | 1 | 0.75 | 0.62 | 0.23 |
| Model 2 | 1 | 1.39 | 0.74 | 0.55 | 1 | 0.65 | 0.25 | <0.01 | 1 | 0.70 | 0.59 | 0.22 |
| Low muscle mass | ||||||||||||
| Crude | 1 | 0.96 | 0.92 | 0.77 | 1 | 1.00 | 0.77 | 0.38 | 1 | 0.88 | 0.88 | 0.66 |
| Model 1 | 1 | 0.89 | 0.84 | 0.62 | 1 | 0.98 | 0.64 | 0.21 | 1 | 0.89 | 0.83 | 0.56 |
| Model 2 | 1 | 1.03 | 1.07 | 0.93 | 1 | 0.93 | 0.54 | 0.10 | 1 | 0.97 | 0.96 | 0.92 |
| Low hand grip strength | ||||||||||||
| Crude | 1 | 1.15 | 1.15 | 0.65 | 1 | 0.58 | 0.50 | 0.02 | 1 | 0.64 | 1.14 | 0.65 |
| Model 1 | 1 | 1.21 | 1.32 | 0.43 | 1 | 0.51 | 0.44 | 0.02 | 1 | 0.59 | 1.29 | 0.49 |
| Model 2 | 1 | 0.80 | 0.94 | 0.55 | 1 | 0.50 | 0.46 | 0.03 | 1 | 0.57 | 1.27 | 0.53 |
| Low gait speed (m/s) | ||||||||||||
| Crude | 1 | 1.13 | 0.74 | 0.31 | 1 | 1.17 | 0.62 | 0.11 | 1 | 0.75 | 0.53 | 0.03 |
| Model 1 | 1 | 1.15 | 0.83 | 0.60 | 1 | 1.31 | 0.78 | 0.52 | 1 | 0.72 | 0.48 | 0.03 |
| Model 2 | 1 | 1.17 | 1.19 | 0.67 | 1 | 1.40 | 0.99 | 0.92 | 1 | 0.66 | 0.46 | 0.03 |
Model 1: Adjusted for age, sex, and energy intake.
Model 2: Further adjusted for physical activity, smoking, alcohol consumption, medication use (statin, corticosteroid, estrogen, testosterone), and positive history of disease.
.
.
Gait speeds lower than 0.8 m/s were considered low (.